Carregant...
IMMU-14. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT
Glioblastoma multiforme is an incurable primary brain tumor. The current standard of care consists of resection followed by radiation and chemotherapy; associated with a median overall survival of 14.6 months. To overcome this dismal outcome, clinicians are turning to immunotherapeutic approaches, w...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692474/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.473 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|